Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001422848-25-000234·Capital Research Global Investors
Schedule 13G ownership disclosure
GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK
Common Stock · CUSIP: 36266G107
Event date: 2025-09-30
- Filing-level shares
- 24,972,556.00
- Percent of class
- 5.5%
- Capital Research Global Investors
Shares: 24,972,556.00 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-25-000234
- Form type
- SCHEDULE 13G
- Filer
- Capital Research Global Investors
- CIK
- CIK 1422848
- Filed
- Nov 13, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership